GKOS
GLAUKOS Corp
NYSE · Healthcare · Medical - Devices · US
$163.81
+1.48%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- -$0.12
- Revenue estimate
- $167.9M
Latest reported
- Last report date
- Jul 29, 2026
- EPS actual
- -$0.14
- EPS estimate
- -$0.21
- Revenue actual
- $185.6M
- Revenue estimate
- $150.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +21.7%
- Revenue beats (12Q)
- 12
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $193
- PT range
- $172 – $215
- Analysts
- 9
8 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 29, 2026 | -$0.21 | -$0.14 | Beat 33.50% | $185.6M |
| Apr 29, 2026 | -$0.30 | -$0.18 | Beat 40.00% | $150.6M |
| Feb 17, 2026 | -$0.22 | -$0.28 | Miss -27.27% | $143.1M |
| Oct 29, 2025 | -$0.27 | -$0.16 | Beat 40.74% | $133.5M |
| Jul 30, 2025 | -$0.26 | -$0.24 | Beat 7.69% | $124.1M |
| Apr 30, 2025 | -$0.33 | -$0.22 | Beat 33.33% | $106.7M |
| Feb 20, 2025 | -$0.38 | -$0.40 | Miss -5.26% | $105.5M |
| Jul 31, 2024 | -$0.52 | -$0.52 | In line | $95.7M |
| May 1, 2024 | -$0.58 | -$0.70 | Miss -20.69% | $85.6M |
| Feb 21, 2024 | -$0.56 | -$0.63 | Miss -12.50% | $82.4M |
| Nov 1, 2023 | -$0.56 | -$0.50 | Beat 10.71% | $78.0M |
| Aug 2, 2023 | -$0.57 | -$0.55 | Beat 3.51% | $80.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026